1. Dai, Dongfang, Pei, Yifei, Zhu, Biqing, Huang, Mingzhu, Xiao, Yichuan. 2024. Chemoradiotherapy-induced ACKR2+ tumor cells drive CD8+ T cell senescence and cervical cancer recurrence. In Cell reports. Medicine, 5, 101550. doi:10.1016/j.xcrm.2024.101550. https://pubmed.ncbi.nlm.nih.gov/38723624/
2. Chang, Tsung-Ming, Chiang, Yao-Chang, Lee, Chiang-Wen, Liu, Ju-Fang, Kou, Yu Ru. 2023. CXCL14 promotes metastasis of non-small cell lung cancer through ACKR2-depended signaling pathway. In International journal of biological sciences, 19, 1455-1470. doi:10.7150/ijbs.79438. https://pubmed.ncbi.nlm.nih.gov/37056937/
3. Dong, Hongxiu, Zhou, Shijie, Chen, Xuxi, Deng, Xuejie, Fang, Aiping. 2024. Pan-cancer analysis of the prognostic significance of ACKR2 expression and the related genetic/epigenetic dysregulations. In Expert review of clinical immunology, 20, 225-236. doi:10.1080/1744666X.2023.2274361. https://pubmed.ncbi.nlm.nih.gov/37882761/
4. Mabuchi, Tomotaka, Hwang, Samuel T. . ACKR2: Nature's Decoy Receptor Lures Unsuspecting Chemokines in Psoriasis. In The Journal of investigative dermatology, 137, 7-11. doi:10.1016/j.jid.2016.09.035. https://pubmed.ncbi.nlm.nih.gov/28010760/
5. Shams, Kave, Kurowska-Stolarska, Mariola, Schütte, Fabian, McKimmie, Clive S, Graham, Gerard J. 2017. MicroRNA-146 and cell trauma down-regulate expression of the psoriasis-associated atypical chemokine receptor ACKR2. In The Journal of biological chemistry, 293, 3003-3012. doi:10.1074/jbc.M117.809780. https://pubmed.ncbi.nlm.nih.gov/29279330/
6. Woodcock, Thomas M, Frugier, Tony, Nguyen, Tan Thanh, Locati, Massimo, Morganti-Kossmann, Maria Cristina. 2017. The scavenging chemokine receptor ACKR2 has a significant impact on acute mortality rate and early lesion development after traumatic brain injury. In PloS one, 12, e0188305. doi:10.1371/journal.pone.0188305. https://pubmed.ncbi.nlm.nih.gov/29176798/
智鼠故事 
